Ashland Reports Higher Q4 Sales and Earnings Driven by Pharma Growth
Nov 5, 2026
Ashland Global Holdings reported higher Q4 sales and adjusted earnings driven by pharmaceutical and personal care product growth. The company provided fiscal 2027 guidance projecting sales between $1.905 billion and $1.975 billion.